JBIO
Financials
- Market Capitalization 1.36 B
- Employee 55
- Founded 2024
- CEO N/A
- Website www.jadebiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00WGHZFH4
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2251 |  VOR Vor Biopharma Inc. - Common Stock | 23.05 USD | -2.04% | -2.08% | +13.88% | +75.95% | 1.36 B USD | ||
| 2263 |  MGTX MeiraGTx Holdings plc - Ordinary Shares | 14.14 USD | -2.88% | -1.87% | +20.85% | +61.60% | 1.36 B USD | ||
| 2288 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 15.34 USD | -1.22% | -3.28% | -17.48% | +60.46% | 1.31 B USD | ||
| 2298 |  MNKD MannKind Corporation - Common Stock | 4.02 USD | -0.99% | -6.73% | +3.08% | -24.15% | 1.29 B USD |
Frequently asked questions about Jade Biosciences, Inc. Common Stock
What is the Jade Biosciences, Inc. Common Stock stock price today?
The current price of Jade Biosciences, Inc. Common Stock (JBIO) is 21.40. Over the past 24 hours, the stock has changed by -0.19%. Follow the JBIO chart for real-time price dynamics.
What is the stock ticker of Jade Biosciences, Inc. Common Stock?
Jade Biosciences, Inc. Common Stock trades under the ticker JBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Jade Biosciences, Inc. Common Stock stock going up?
JBIO has changed by -0.88% over the last week, +6.95% over the last month, and +112.94% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Jade Biosciences, Inc. Common Stock?
Jade Biosciences, Inc. Common Stock currently has a market capitalization of 1.36 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Jade Biosciences, Inc. Common Stock earnings last quarter?
Last quarter, Jade Biosciences, Inc. Common Stock reported earnings of -0.76 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Jade Biosciences, Inc. Common Stock net income for the last quarter?
Jade Biosciences, Inc. Common Stock reported net income of -55.77 M for the last quarter. The previous quarter showed -40.37 M, which means net income changed by -38.14%.
How many employees does Jade Biosciences, Inc. Common Stock have?
As of the latest available data, Jade Biosciences, Inc. Common Stock has 55 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Jade Biosciences, Inc. Common Stock stock?
You can buy Jade Biosciences, Inc. Common Stock (JBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Jade Biosciences, Inc. Common Stock stock?
Investing in Jade Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the JBIO chart and related analysis on metatrader.com as part of your research.